The U.S. medical weight loss clinics market size was estimated at USD 1.17 billion in 2024 and is projected to grow at a CAGR of 4.42% from 2025 to 2030. The growing prevalence of obesity has become a significant driver for the market growth. The Centers for Disease Control and Prevention (CDC) reports that from August 2021 to August 2023, more than 40% of adults in the U.S. were classified as obese, with more than one in three adults affected in 23 states. This trend is raising concerns about public health and the rising demand for specialized weight loss services. Obesity is associated with numerous chronic conditions, including heart disease, diabetes, and hypertension, which increases the need for effective weight management solutions. In addition, the estimated annual medical cost of obesity in the U.S. is approximately USD 173 billion, highlighting the financial burden this health crisis imposes on the healthcare system.
Medical weight loss clinics offer personalized approaches to help individuals achieve sustainable weight loss, increasing demand in the U.S. medical weight loss clinics industry. As obesity continues to rise, several people are turning to these clinics for medically supervised treatments such as prescription weight loss medications, meal plans, and counseling. For instance, the growing popularity of GLP-1 medications, including Semaglutide, became a significant trend in weight loss clinics. These medications have shown significant results in helping patients lose weight, driving the nationwide demand for medical services. As awareness of the health risks associated with obesity grows, more people seek professional help, pushing the expansion of this market.
Procedures such as gastric bypass or bariatric surgery are considered expensive, involving high initial costs for surgery, hospital stays, post-operative care, and potential complications. According to the American Society for Metabolic and Bariatric Surgery, the average price of bariatric surgery in the U.S. is around USD 17,000 to USD 26,000. These financial burdens prevent individuals from choosing surgical weight loss treatments. Hence, several people seek affordable alternatives, turning to non-surgical medical weight loss programs that offer a lower cost option with similar benefits, such as medical supervision, weight loss medications, and behavioral counseling.
Surgical Weight Loss Treatment V/S Non-Surgical Weight Loss Treatment
Sr.No. |
Basis |
Surgical Weight Loss Treatment |
Non-Surgical Weight Loss Treatment |
1 |
Types of Treatment |
Gastric bypass, sleeve gastrectomy, adjustable gastric banding. |
Prescription medications, lifestyle and dietary counseling, weight loss injections (GLP-1 drugs), and behavioral therapy |
2 |
Invasiveness |
Highly invasive, requires incisions and surgery |
Non-invasive, no surgery required |
3 |
Cost |
High, includes surgery, hospital stay, and post-op care |
Generally lower, depending on the program and medications |
4 |
Recovery Time |
Long recovery time, often weeks to months |
Minimal to no recovery time |
5 |
Risks |
Includes soreness, bleeding, and infection |
Mild redness, swelling, or discomfort in the treated area |
Source: Secondary Research- Livglam Anti-Ageing Clinics, Grand View Research
In response to the rising costs of surgical treatments, medical weight loss clinics capitalized on the demand for cost-effective solutions by offering comprehensive, non-invasive programs. These programs include prescription weight loss medications, personalized diet plans, and other affordable non-surgical interventions while providing effective weight management results. With the growing preference for less invasive options and the rising financial barriers of surgery, medical weight loss clinics are placing themselves as an alternative for individuals seeking weight loss solutions that fit their budget and lifestyle.
The rising aesthetic desire to achieve a fit and toned body influenced the growing demand for medical weight loss clinics in the U.S. As society places value on physical appearance, individuals focus on looking lean and healthy. This shift in mindset is driving people to seek out weight loss solutions that help them achieve their desired body image. Aesthetic goals, such as completing a slimmer waistline or toned physique, are as crucial as health-related concerns. The growing awareness of body image and the desire to improve one's physical appearance is pushing people to explore various weight loss options, especially those that are less invasive and require minimal downtime.
The chart below illustrates the relationship between industry concentration, industry characteristics, and industry participants. The x-axis represents the level of industry concentration, ranging from low to high. The y-axis represents various industry characteristics, including industry competition, degree of innovation, impact of regulations, level of partnership & collaboration activities, and geographic expansion. The industry is highly fragmented, with numerous smaller, independent clinics alongside a few larger players offeringa variety of specialized services and customized solutions. The degree of innovation is moderate, and the impact of regulations on industry is high. The level of partnership & acquisition activities is moderate, and geographic expansion of the industry is high.
The U.S. medical weight loss clinics market has exhibited a notable degree of innovation in recent years, driven by the integration of advanced pharmaceuticals and digital health platforms. A significant development is the incorporation of GLP-1 receptor agonists, such as Eli Lilly's Zepbound and Novo Nordisk's Wegovy, into treatment regimens. These medications have gained popularity due to their efficacy in weight management, contributing to the market's expansion. Telehealth companies have capitalized on this trend by offering virtual consultations and prescription services for these medications. In April 2025, the primary care organization knownwell partnered with LillyDirect to provide weight-management services. Patients enrolled in LillyDirect will have the opportunity to receive personalized care from physicians at knownwell.
According to the International Association for Physicians in Aesthetic Medicine (IAPAM) published article, starting a medical weight management clinic in the U.S. requires compliance with specific state regulations that vary by location. Physicians register the practice with the state and ensure a qualified physician leads it. In addition, some states, such as California, New York, Florida, and Texas, mandate that specific certifications or licenses be obtained to offer weight management services legally. Researching and following these local laws is crucial to ensure the clinic operates within legal boundaries.
Treatment |
Typical Insurance Coverage |
Prescription Weight-Loss Medications |
Minimal coverage. Medicare Part D cannot cover drugs for obesity by law. Most private plans are not required to cover anti-obesity meds and often don’t. Some employers opt-in, but fewer than 20% of employer health plans covered newer GLP-1 weight loss drugs as of 2023 (most only cover them for diabetes). Medicaid coverage varies by state (only 13 state Medicaid programs covered GLP-1 obesity drugs as of 2024). |
Dietary/Behavioral Counseling |
Limited coverage. ACA-compliant plans must cover obesity counseling (usually via primary care) with no patient cost. However, these services are often limited in frequency or duration. Medicare, for instance, covers intensive behavioral therapy for obesity in primary care settings under strict scheduling guidelines, but this benefit is underutilized. Coverage for dietitians or weight management coaches outside primary care is inconsistent, often requiring patients to pay out-of-pocket after a few initial sessions. |
Physician-Supervised Programs (clinic-based) |
Often not a covered benefit. Insurance typically does not reimburse the program fees or medical supervision at dedicated weight loss clinics. Some clinics bill individual services (office visits, lab tests) to insurance, but comprehensive program costs (meal replacements, coaching, supplements) are usually out-of-pocket. A few large clinic franchises have negotiated partial coverage with certain insurers, but this is the exception rather than the norm. The result is that most patients must self-pay to enroll in medical weight loss programs. |
The merger & acquisition activity in the market is moderate, driven by increasing demand for personalized healthcare services, cost efficiency, and enhanced delivery service. Market players are forming strategic alliances with various stakeholders, including other healthcare providers, technology companies, and community organizations. For instance, in July 2024, Sanford Health and Marshfield Clinic Health System announced a USD 10 billion merger plan. The combined system aims to improve patient outcomes through broader population health initiatives and value-based care programs. This integrated approach can benefit patients seeking weight loss solutions by addressing underlying health issues.
The U.S. medical weight loss clinics industry is experiencing significant geographic expansion, driven by increasing demand for weight management services and the rising prevalence of obesity. In November 2024, Options Medical Weight Loss marked its expansion in Central Ohio with the grand opening of a new clinic in Upper Arlington.
The standalone segment dominated the market with a revenue share of 60.33% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. Standalone clinics gained significance in the U.S. market due to their ability to offer specialized, personalized weight loss programs tailored to individual needs. These clinics operate independently, focusing exclusively on weight management and allowing customized approaches. Patients prefer standalone clinics as they typically offer a broader range of services, such as medical consultations, dietary guidance, exercise plans, and behavioral therapy, all under one roof. In addition, the non-hospital setting is seen as less intimidating and more accessible, providing a comfortable environment for patients to seek treatment without the complexities of larger medical institutions. Furthermore, increasing launches of standalone clinics in the U.S. are fostering segmental growth. For instance, in August 2022, Modern Medical Weight Loss opened a new medical weight loss clinic in Kentucky offering advanced medical weight loss solutions.
The hospital-based segment is expected to experience significant growth over the forecast period due to the availability of advanced technologies and well-established physician networks across the U.S. Several major hospitals, including Cleveland Clinic, Johns Hopkins Health System, Cedar-Sinai, and many others, offer medical weight loss programs in the U.S. Hospitals are expanding their weight loss programs to include medically supervised treatments such as behavioral therapy, nutritional counseling, and medication management, capitalizing on their established infrastructure and expert teams.
The Southeast segment held the largest revenue share of 23.89% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. The Southeast region of the U.S. medical weight loss clinics industry is rapidly growing, driven by demographic trends, increasing obesity rates, and rising awareness of the health risks associated with excess weight. This region includes Alabama, Florida, Georgia, Kentucky, Maryland, and Mississippi, where obesity rates are higher than the national average. As the prevalence of obesity-related health issues such as diabetes, hypertension, and heart disease continues to rise, there has been an increasing demand for medical weight loss services that provide practical, medically supervised programs. According to the Centre for Disease Control and Prevention, in 2023, the South region of the U.S. had an obesity prevalence of 34.7%, making it one of the areas with the highest rates, with more than 1 in 3 adults affected.
The Southwest segment is projected to witness lucrative growth during the forecast period. The Southwest region of the U.S. market, including states such as Arkansas, Delaware, Louisiana, and Oklahoma, saw significant growth due to high obesity rates, a diverse population, and increasing healthcare access. Obesity prevalence in the Southwest is above the national average, making the demand for effective weight management solutions even more noticeable.
This market features a diverse competitive landscape comprising hospital-affiliated programs and standalone clinics. Prominent hospital-based providers include Cleveland Clinic, NYU Langone Hospitals, Stanford Health Care, and UCLA Health, which offer comprehensive weight management services integrated with their broader healthcare offerings. In the standalone segment, key players such as Medical Weight Loss Clinic, Rivas Weight Loss, and Medi-Weightloss operate numerous locations nationwide, providing specialized services focused solely on weight management.
The market has also seen the emergence of telehealth platforms like Hims & Hers Health, which have expanded their services to include weight loss treatments, notably incorporating medications like Eli Lilly's Zepbound. In addition, collaborations between primary care firms and pharmaceutical companies, exemplified by knownwell's partnership with LillyDirect, are enhancing the accessibility and personalization of weight management services.
In April 2025, the University of Arkansas for Medical Sciences (UAMS) introduced bariatric surgery as an option for weight loss at the UAMS Health Medical and Surgical Weight Management Clinic.
In November 2024, Allurion Technologies, Inc., a firm focused on combating obesity, revealed the introduction of AllurionMeds, an innovative solution for patients that pairs cost-effective and easily accessible weight loss medications with the company's AI-enabled platform, which includes Coach Iris to support sustained weight management, virtual access to nutritionists, and a smart scale that tracks weight and muscle and bone mass.
In October 2024, the Cleveland Clinic received funding from the Patient-Centered Outcomes Research Institute (PCORI) to implement a lifestyle intervention obesity treatment model throughout its primary care practices in Northeast Ohio.
In January 2024, Options Medical Weight Loss, part of the Thurston Group portfolio and recognized as the leading medical weight loss clinic in the nation, revealed an ambitious expansion strategy aimed at lowering the national year-over-year obesity growth rate through transformative and positive experiences. This expansion will involve opening new locations in both established and new markets, including Atlanta, Charlotte, Raleigh, and Philadelphia.
Report Attribute |
Details |
Revenue forecast in 2030 |
USD 1.50 billion |
Growth rate |
CAGR of 4.42% from 2025 to 2030 |
Actual data |
2018 - 2024 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million/billion, and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Ownership, region |
Country scope |
U.S. |
Key companies profiled |
Medi-Weightloss; Medical Weight Loss Clinic; Rivas Weight Loss; NYU Langone Hospitals; Cleveland Clinic; Stanford Health Care; UCLA Health; Long Island Weight Loss Institute; Cedars-Sinai; Allegheny Health Network; Options Medical Weight Loss; Med-Fit Medical Weight Loss |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. medical weight loss clinics market report-based ownership and region:
Ownership Outlook (Revenue, USD Million, 2018 - 2030)
Hospital-based
Standalone
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Northeast
Southeast
Southwest
Midwest
West
b. The U.S. medical weight loss clinics market size was estimated at USD 1.17 billion in 2024 and is expected to reach USD 1.21 billion in 2025.
b. The U.S. medical weight loss clinics market is expected to grow at a compound annual growth rate of 4.42% from 2025 to 2030 to reach USD 1.50 billion by 2030.
b. Standalone segment dominated the U.S. medical weight loss clinics market with a share of 60.33% in 2024 due to their ability to offer specialized, personalized weight loss programs tailored to individual needs.
b. Some key players operating in the U.S. medical weight loss clinics market are Medi-Weightloss, Medical Weight Loss Clinic, Rivas Weight Loss, NYU Langone Hospitals, Cleveland Clinic, Stanford Health Care, UCLA Health, Long Island Weight Loss Institute, Cedars-Sinai, Allegheny Health Network, Options Medical Weight Loss, Med-Fit Medical Weight Loss.
b. Key factors that are driving the U.S. medical weight loss clinics market growth include growing prevalence of obesity, rising costs of surgical treatments, and rising aesthetic desire to achieve a fit and toned body.
NEED A CUSTOM REPORT?
We offer custom report options, including stand-alone sections and country-level data. Special pricing is available for start-ups and universities.
Request CustomizationWe are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."